Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy

被引：0
|
作者：
Maron B.J. [1 ]
机构：
[1] Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407
来源：
Current Cardiology Reports | 2000年 / 2卷 / 2期
关键词：
Hypertrophic Cardiomyopathy; Obstructive Hypertrophic Cardiomyopathy; Pace Study; Left Ventricular Outflow Tract Gradient; Septal Myectomy;
D O I：
10.1007/s11886-000-0009-2
中图分类号：
学科分类号：
摘要：
Hypertrophic cardiomyopathy (HCM) is a genetically transmitted cardiac disease with a heterogeneous clinical expression and natural history [1]. A small but important proportion of patients with HCM develop exertional symptoms of dyspnea and chest pain refractory to drug treatment and have obstruction to left ventricular outflow under basal conditions (gradient, 50 mm Hg). Such patients probably constitute about 5% of the overall patient population with HCM at any one cross-sectional point in time. Copyright © 2000 by Current Science Inc.
引用
收藏
页码：131 / 133
页数：2
相关论文
共 50 条
  • [1] EFFECTS OF DUAL-CHAMBER PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    JEANRENAUD, X
    GOY, JJ
    KAPPENBERGER, L
    [J]. LANCET, 1992, 339 (8805): : 1318 - 1323
  • [2] Effects of dual-chamber pacing for pediatric patients with hypertrophic obstructive cardiomyopathy
    Rishi, F
    Hulse, JE
    Auld, DO
    McRae, G
    Kaltman, J
    Kanter, K
    Williams, W
    Campbell, RM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (04) : 734 - 740
  • [3] Symptomatic hypertrophic obstructive cardiomyopathy: The role of dual-chamber pacing
    Park, MH
    Gilligan, DM
    Bernardo, NL
    Topaz, O
    [J]. ANGIOLOGY, 1999, 50 (02) : 87 - 94
  • [4] DUAL-CHAMBER PACING IN HYPERTROPHIC CARDIOMYOPATHY
    CHENG, TO
    [J]. PHYSICIAN AND SPORTSMEDICINE, 1994, 22 (02): : 26 - &
  • [5] Dual-chamber pacing in hypertrophic cardiomyopathy
    Gilligan D.M.
    [J]. Current Cardiology Reports, 2000, 2 (2) : 154 - 159
  • [6] TEMPORARY DUAL-CHAMBER PACING IN PEDIATRIC-PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    RISHI, F
    HULSE, JE
    SHARMA, S
    AULD, D
    CAMPBELL, RM
    [J]. CIRCULATION, 1993, 88 (04) : 485 - 485
  • [7] PERMANENT DUAL-CHAMBER PACING IN PEDIATRIC-PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    RISHI, F
    HULSE, JE
    SHARMA, S
    KANTER, KR
    WILLIAMS, WH
    DOOLEY, KJ
    AULD, D
    MCRAE, GJ
    CLARK, LJ
    CAMPBELL, RM
    [J]. CIRCULATION, 1994, 90 (04) : 98 - 98
  • [8] Synergistic effect of dual-chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy
    Minami, Y.
    Kajimoto, K.
    Okayama, D.
    Nakao, M.
    Hagiwara, N.
    Kawana, M.
    Kasanuki, H.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 59 - 59
  • [9] IMPACT OF DUAL-CHAMBER PERMANENT PACING IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY WITH SYMPTOMS REFRACTORY TO VERAPAMIL AND BETA-ADRENERGIC BLOCKER THERAPY
    FANANAPAZIR, L
    CANNON, RO
    TRIPODI, D
    PANZA, JA
    [J]. CIRCULATION, 1992, 85 (06) : 2149 - 2161
  • [10] Long-term outcome of patients with obstructive hypertrophic cardiomyopathy with dual-chamber pacing
    Kato, YYoshinobu
    Suzuki, A.
    Minami, Y.
    Yazaki, K.
    Haruki, S.
    Serizawa, N.
    Shiga, T.
    Shoda, M.
    Hagiwara, N.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 326 - 326
12345